Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
Table 1
Baseline characteristics of the participants with various subtypes of polypoidal choroidal vasculopathy.
Subtype 1
Subtype 2
Patients (n)
24
23
Gender (n), female/male
8/16
10/13
0.556
Age (year), mean ± SD
64.3 ± 7.6
61.3 ± 8.0
0.184
Best-corrected visual acuity (logMAR), mean ± SD
0.54 ± 0.36
0.55 ± 0.37
0.965
Optical coherence tomography features
Continuous external limiting membrane (n)
2
3
0.666
Continuous ellipsoid zone (n)
0
2
0.234
Continuous retinal pigment epithelium (n)
6
17
0.001
Intraretinal fluid (n)
15
11
0.375
Subretinal fluid (n)
11
18
0.036
Indocyanine green angiography features
Greatest linear dimension (μm), mean ± SD
3859.7 ± 1625.6
1862.0 ± 1011.0
<0.001
The distance from foveola to the nearest polyp (μm), mean ± SD
1897.2 ± 1126.4
655.5 ± 540.7
<0.001
The distance from foveola to branching vascular network (μm), mean ± SD
255.1 ± 497.4
340.7 ± 433.2
0.551
Configuration of polyps (n), isolated/interconnected
